Concepts (162)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Uterine Cervical Neoplasms | 2 | 2023 | 275 | 1.270 |
Why?
|
| Papillomavirus Infections | 2 | 2023 | 239 | 1.260 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2023 | 27 | 0.880 |
Why?
|
| Lifting | 1 | 2020 | 12 | 0.750 |
Why?
|
| Endoscopic Mucosal Resection | 1 | 2020 | 21 | 0.730 |
Why?
|
| Rhabdomyosarcoma | 1 | 2019 | 40 | 0.700 |
Why?
|
| Cytodiagnosis | 1 | 2019 | 42 | 0.680 |
Why?
|
| Phyllodes Tumor | 1 | 2018 | 7 | 0.660 |
Why?
|
| Papillomaviridae | 1 | 2019 | 153 | 0.630 |
Why?
|
| Prostatic Neoplasms | 2 | 2019 | 1721 | 0.610 |
Why?
|
| Mutation | 3 | 2019 | 3968 | 0.530 |
Why?
|
| Epithelial Cells | 2 | 2018 | 669 | 0.500 |
Why?
|
| Anastomotic Leak | 2 | 2013 | 96 | 0.490 |
Why?
|
| Biomarkers, Tumor | 2 | 2019 | 1464 | 0.490 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2013 | 194 | 0.480 |
Why?
|
| Spinal Cord Injuries | 2 | 2018 | 54 | 0.430 |
Why?
|
| Neuroendocrine Tumors | 2 | 2022 | 105 | 0.370 |
Why?
|
| Intestines | 2 | 2012 | 411 | 0.360 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2010 | 52 | 0.360 |
Why?
|
| Colectomy | 1 | 2010 | 167 | 0.340 |
Why?
|
| Cross Infection | 1 | 2010 | 141 | 0.340 |
Why?
|
| Neoplasm Grading | 2 | 2019 | 357 | 0.300 |
Why?
|
| Early Detection of Cancer | 2 | 2023 | 395 | 0.300 |
Why?
|
| Pancreatic Neoplasms | 2 | 2022 | 645 | 0.280 |
Why?
|
| Phospholipases A | 1 | 2006 | 45 | 0.280 |
Why?
|
| Neuroprotective Agents | 1 | 2006 | 94 | 0.270 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 2357 | 0.240 |
Why?
|
| Ki-67 Antigen | 1 | 2023 | 64 | 0.220 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2023 | 104 | 0.210 |
Why?
|
| Phosphates | 2 | 2012 | 160 | 0.200 |
Why?
|
| Anastomosis, Surgical | 2 | 2013 | 267 | 0.200 |
Why?
|
| Colonic Pouches | 1 | 2022 | 67 | 0.200 |
Why?
|
| Proctocolectomy, Restorative | 1 | 2022 | 87 | 0.200 |
Why?
|
| Inflammation | 3 | 2022 | 923 | 0.190 |
Why?
|
| Celiac Disease | 1 | 2023 | 203 | 0.190 |
Why?
|
| Oxidative Stress | 2 | 2018 | 448 | 0.190 |
Why?
|
| Humans | 14 | 2023 | 86678 | 0.190 |
Why?
|
| Injections | 1 | 2020 | 109 | 0.180 |
Why?
|
| Carcinoma, Mucoepidermoid | 1 | 2019 | 17 | 0.170 |
Why?
|
| Diclofenac | 1 | 2018 | 4 | 0.170 |
Why?
|
| Biopsy | 2 | 2023 | 1163 | 0.170 |
Why?
|
| L-Selectin | 1 | 2018 | 16 | 0.170 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2019 | 66 | 0.160 |
Why?
|
| Gene Rearrangement | 1 | 2019 | 170 | 0.160 |
Why?
|
| Metaplasia | 1 | 2018 | 37 | 0.160 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2022 | 645 | 0.160 |
Why?
|
| GATA3 Transcription Factor | 1 | 2018 | 48 | 0.160 |
Why?
|
| Kallikreins | 1 | 2018 | 47 | 0.160 |
Why?
|
| Triage | 1 | 2019 | 108 | 0.160 |
Why?
|
| Myeloid Cells | 1 | 2018 | 98 | 0.160 |
Why?
|
| Leukocytes | 1 | 2018 | 202 | 0.150 |
Why?
|
| Endoscopy | 1 | 2020 | 332 | 0.150 |
Why?
|
| Trans-Activators | 1 | 2019 | 429 | 0.140 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 243 | 0.140 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 456 | 0.140 |
Why?
|
| Prostate-Specific Antigen | 1 | 2018 | 353 | 0.140 |
Why?
|
| Phenotype | 4 | 2022 | 2380 | 0.140 |
Why?
|
| Immunohistochemistry | 2 | 2018 | 1753 | 0.140 |
Why?
|
| Crohn Disease | 1 | 2022 | 730 | 0.130 |
Why?
|
| Colitis, Ulcerative | 1 | 2022 | 711 | 0.130 |
Why?
|
| Male | 8 | 2019 | 40988 | 0.120 |
Why?
|
| Genotype | 1 | 2019 | 1852 | 0.120 |
Why?
|
| Intestinal Mucosa | 2 | 2023 | 797 | 0.120 |
Why?
|
| Caenorhabditis elegans | 2 | 2012 | 223 | 0.120 |
Why?
|
| Radiation | 1 | 2012 | 15 | 0.110 |
Why?
|
| Models, Biological | 2 | 2013 | 1749 | 0.110 |
Why?
|
| Protective Agents | 1 | 2012 | 33 | 0.110 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2012 | 70 | 0.110 |
Why?
|
| Apoptosis | 2 | 2012 | 1683 | 0.110 |
Why?
|
| Candida albicans | 1 | 2012 | 32 | 0.100 |
Why?
|
| Middle Aged | 3 | 2019 | 25040 | 0.100 |
Why?
|
| Rats, Wistar | 1 | 2012 | 297 | 0.100 |
Why?
|
| Tight Junctions | 1 | 2012 | 149 | 0.100 |
Why?
|
| Female | 5 | 2023 | 44550 | 0.100 |
Why?
|
| DNA Repair | 2 | 2022 | 356 | 0.100 |
Why?
|
| Adult | 4 | 2023 | 25659 | 0.100 |
Why?
|
| Molecular Sequence Data | 2 | 2012 | 3030 | 0.100 |
Why?
|
| Host-Pathogen Interactions | 1 | 2013 | 231 | 0.090 |
Why?
|
| Metagenome | 1 | 2011 | 102 | 0.090 |
Why?
|
| Wound Healing | 1 | 2012 | 344 | 0.090 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2010 | 44 | 0.090 |
Why?
|
| Polyethylene Glycols | 1 | 2012 | 364 | 0.090 |
Why?
|
| Gastrointestinal Tract | 1 | 2012 | 191 | 0.090 |
Why?
|
| Rats | 2 | 2013 | 3992 | 0.090 |
Why?
|
| Critical Illness | 1 | 2012 | 294 | 0.090 |
Why?
|
| Colon | 1 | 2012 | 496 | 0.080 |
Why?
|
| Recovery of Function | 1 | 2010 | 272 | 0.080 |
Why?
|
| Base Sequence | 1 | 2012 | 2330 | 0.080 |
Why?
|
| Computer Simulation | 1 | 2013 | 1078 | 0.080 |
Why?
|
| Mesons | 1 | 2007 | 9 | 0.080 |
Why?
|
| Brain Injuries | 1 | 2010 | 161 | 0.080 |
Why?
|
| Color | 1 | 2007 | 81 | 0.080 |
Why?
|
| Hippocampus | 1 | 2010 | 442 | 0.070 |
Why?
|
| Phospholipases A2 | 1 | 2006 | 44 | 0.070 |
Why?
|
| Methylprednisolone | 1 | 2006 | 66 | 0.070 |
Why?
|
| Cerebral Cortex | 1 | 2010 | 584 | 0.070 |
Why?
|
| Netropsin | 1 | 2004 | 1 | 0.060 |
Why?
|
| Acetaldehyde | 1 | 2004 | 7 | 0.060 |
Why?
|
| Mutagens | 1 | 2004 | 31 | 0.060 |
Why?
|
| Aged | 2 | 2019 | 18423 | 0.060 |
Why?
|
| Animals | 6 | 2018 | 26590 | 0.060 |
Why?
|
| DNA Glycosylases | 1 | 2004 | 24 | 0.060 |
Why?
|
| Adenine | 1 | 2004 | 85 | 0.060 |
Why?
|
| Astrocytes | 1 | 2004 | 139 | 0.060 |
Why?
|
| Immunoglobulin A | 1 | 2023 | 80 | 0.060 |
Why?
|
| Duodenum | 1 | 2023 | 100 | 0.060 |
Why?
|
| Reactive Oxygen Species | 1 | 2006 | 480 | 0.060 |
Why?
|
| Mice, Knockout | 3 | 2018 | 1924 | 0.060 |
Why?
|
| Cerebellum | 1 | 2004 | 247 | 0.050 |
Why?
|
| Mitotic Index | 1 | 2022 | 20 | 0.050 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2022 | 46 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 3 | 2018 | 3095 | 0.050 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2022 | 72 | 0.050 |
Why?
|
| 5-Methylcytosine | 1 | 2022 | 112 | 0.050 |
Why?
|
| Child | 2 | 2023 | 6928 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2018 | 2231 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2019 | 348 | 0.040 |
Why?
|
| Mice | 4 | 2018 | 11356 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 1208 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2022 | 481 | 0.040 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2010 | 121 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 2706 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2023 | 3642 | 0.040 |
Why?
|
| Time Factors | 2 | 2019 | 5214 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 1673 | 0.030 |
Why?
|
| Bacterial Translocation | 1 | 2013 | 26 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 1313 | 0.030 |
Why?
|
| Bacterial Adhesion | 1 | 2013 | 84 | 0.030 |
Why?
|
| Cell Membrane Permeability | 1 | 2013 | 119 | 0.030 |
Why?
|
| Acid Phosphatase | 1 | 2012 | 33 | 0.030 |
Why?
|
| Pseudomonas Infections | 1 | 2013 | 95 | 0.030 |
Why?
|
| Biofilms | 1 | 2012 | 42 | 0.030 |
Why?
|
| Microbiological Techniques | 1 | 2011 | 24 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2013 | 989 | 0.020 |
Why?
|
| Fungal Proteins | 1 | 2012 | 141 | 0.020 |
Why?
|
| Genetic Techniques | 1 | 2011 | 72 | 0.020 |
Why?
|
| Rotarod Performance Test | 1 | 2010 | 9 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 2271 | 0.020 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2010 | 20 | 0.020 |
Why?
|
| Symbiosis | 1 | 2011 | 118 | 0.020 |
Why?
|
| Feces | 1 | 2012 | 319 | 0.020 |
Why?
|
| Hand Strength | 1 | 2010 | 51 | 0.020 |
Why?
|
| Cell Count | 1 | 2010 | 195 | 0.020 |
Why?
|
| Risk Factors | 1 | 2019 | 5420 | 0.020 |
Why?
|
| General Surgery | 1 | 2011 | 229 | 0.020 |
Why?
|
| Neurons | 2 | 2010 | 1547 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 6513 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 2010 | 212 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2012 | 853 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2022 | 8496 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2010 | 912 | 0.020 |
Why?
|
| Motor Activity | 1 | 2010 | 327 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2013 | 2819 | 0.020 |
Why?
|
| Young Adult | 1 | 2019 | 5980 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 1135 | 0.020 |
Why?
|
| Adolescent | 1 | 2019 | 8984 | 0.020 |
Why?
|
| Xeroderma Pigmentosum Group A Protein | 1 | 2004 | 1 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2007 | 482 | 0.020 |
Why?
|
| Alkylating Agents | 1 | 2004 | 32 | 0.020 |
Why?
|
| Glutathione | 1 | 2004 | 104 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2004 | 188 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2004 | 373 | 0.010 |
Why?
|